Sex-specific Trajectories of Measures of Cardiovascular Health During Childhood and Adolescence: A Prospective Cohort Study
Overview
Authors
Affiliations
Background And Aims: Sex differences in measures of cardiovascular health in adults are well documented. However, the sex-specific aetiology of cardiovascular health across childhood and adolescence is poorly understood.
Methods: We examined sex differences in trajectories of 11 measures of cardiovascular health from birth to 18 years, in a contemporary birth cohort study in England (N participants per outcomes: 662-13,985, N repeated measures per outcome: 1,831-112,768). Outcomes were measured over varying time spans from birth or mid-childhood to age 18 and with different numbers of repeated measures per outcome. Analyses were performed using fractional polynomial and linear spline multilevel models.
Results: Females had higher mean BMI, height-adjusted fat mass, pulse rate, insulin, triglycerides, and non-high-density lipoprotein cholesterol (HDL-c) and lower mean height-adjusted lean mass from birth or from mid-childhood to age 18. For example, mean non-HDL-c was 0.07 mmol/l (95% confidence interval (CI), 0.04, 0.10) higher in females compared with males at birth. By age 18, this difference persisted and widened to 0.19 mmol/l (95% CI, 0.16, 0.23) higher non-HDL-c in females compared with males. Females had lower levels of glucose from mid-childhood and developed lower systolic blood pressure and higher HDL-c from mid-adolescence onward. For example, females had 0.08 mmol/l (95% CI, 0.05, 0.10) lower mean glucose compared with males at age seven which widened to a difference of 0.22 mmol/l (95% CI, 0.25, 0.19) at age 18.
Conclusions: Sex differences in measures of cardiovascular health are apparent from birth or mid-childhood and change during early life. These differences may have implications for sex-specific disease risk in future adult populations.
Guo Z, Di J, Zhang Z, Chen S, Mao X, Wang Z Front Pharmacol. 2024; 15:1404427.
PMID: 39286630 PMC: 11402654. DOI: 10.3389/fphar.2024.1404427.
The impact of female sex hormones on cardiovascular disease: from mechanisms to hormone therapy.
Kan Y, Peng Y, Zhao Z, Dong S, Xu Y, Ma X J Geriatr Cardiol. 2024; 21(6):669-681.
PMID: 38973823 PMC: 11224657. DOI: 10.26599/1671-5411.2024.06.003.
Li S, Tan I, Atkins E, Schutte A, Gnanenthiran S Curr Heart Fail Rep. 2024; 21(4):322-336.
PMID: 38861130 PMC: 11333539. DOI: 10.1007/s11897-024-00672-y.
Driscoll D, Kiely E, OKeeffe L, Khashan A Soc Psychiatry Psychiatr Epidemiol. 2024; 59(8):1299-1309.
PMID: 38342824 PMC: 11291537. DOI: 10.1007/s00127-024-02616-2.
Yari-Boroujeni R, Farjad M, Olazadeh K, Cheraghi L, Parvin P, Azizi F Sci Rep. 2023; 13(1):20965.
PMID: 38017282 PMC: 10684687. DOI: 10.1038/s41598-023-48253-8.